Trials / Terminated
TerminatedNCT04759989
Fluid Resuscitation in Septic Shock Patients With BMI Elevation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.
Detailed description
Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1 at present, there are no robust data to support whether dosing based on actual body weight or an alternative correction formula (ideal body weight, adjusted body weight) is superior. FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative resuscitation strategies for obese patients with septic shock, looking at feasibility and safety of different weight-based approaches. Subject treatment assignment will not be blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Actual Body Weight Dosing | 30cc/kg initial bolus calculated using Actual Body Weight |
| PROCEDURE | Adjusted Body Weight Dosing | 30cc/kg initial bolus calculated using Adjusted Body Weight |
| PROCEDURE | Ideal Body Weight Dosing | 30cc/kg initial bolus calculated using Ideal Body Weight |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2022-04-25
- Completion
- 2022-05-25
- First posted
- 2021-02-18
- Last updated
- 2022-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04759989. Inclusion in this directory is not an endorsement.